- Home
- AESI vs ADPT Comparison
AESI vs ADPT Comparison
Compare AESI & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AESI
- ADPT
- Stock Information
- Founded
- AESI 2017
- ADPT 2009
- Country
- AESI United States
- ADPT United States
- Employees
- AESI N/A
- ADPT N/A
- Industry
- AESI Metal Fabrications
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AESI Industrials
- ADPT Health Care
- Exchange
- AESI Nasdaq
- ADPT Nasdaq
- Market Cap
- AESI 1.6B
- ADPT 1.4B
- IPO Year
- AESI 2023
- ADPT 2019
- Fundamental
- Price
- AESI $12.16
- ADPT $9.52
- Analyst Decision
- AESI Buy
- ADPT Buy
- Analyst Count
- AESI 9
- ADPT 6
- Target Price
- AESI $20.17
- ADPT $9.83
- AVG Volume (30 Days)
- AESI 2.1M
- ADPT 2.5M
- Earning Date
- AESI 05-05-2025
- ADPT 05-01-2025
- Dividend Yield
- AESI 7.98%
- ADPT N/A
- EPS Growth
- AESI N/A
- ADPT N/A
- EPS
- AESI 0.30
- ADPT N/A
- Revenue
- AESI $1,160,881,000.00
- ADPT $189,527,000.00
- Revenue This Year
- AESI $16.01
- ADPT $25.00
- Revenue Next Year
- AESI $5.47
- ADPT $20.38
- P/E Ratio
- AESI $40.14
- ADPT N/A
- Revenue Growth
- AESI 77.72
- ADPT 8.61
- 52 Week Low
- AESI $11.76
- ADPT $2.99
- 52 Week High
- AESI $26.86
- ADPT $10.28
- Technical
- Relative Strength Index (RSI)
- AESI 37.08
- ADPT 60.15
- Support Level
- AESI $12.66
- ADPT $8.50
- Resistance Level
- AESI $12.90
- ADPT $9.69
- Average True Range (ATR)
- AESI 0.45
- ADPT 0.44
- MACD
- AESI 0.03
- ADPT -0.01
- Stochastic Oscillator
- AESI 7.74
- ADPT 77.86
About AESI Atlas Energy Solutions Inc.
Atlas Energy Solutions Inc is a provider of proppant and logistics services to the oil and natural gas industry within the Permian Basin of West Texas and New Mexico, the most active oil and natural gas basin in North America. Proppant is necessary to facilitate the recovery of hydrocarbons from oil and natural gas wells. One hundred percent of its sand reserves are located in Winkler and Ward Counties, Texas, within the Permian Basin, and its operations consist of proppant production and processing facilities, including two facilities near Kermit, Texas, and a third facility near Monahans, Texas.
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).